Immunology Update – 3 Jun 2026: Imfinzi Approval, Tremfya Label Expansion and More

Endocrinology Update – 2 Jun 2026: Kerendia Priority Review, Control-IQ+ Clearance and More

Hematology Update – 1 Jun 2026: HEMGENIX Canada Access, VENCLYXTO EU Expansion and More

Vaccine Research Update – 29 May 2026: GSK Arexvy Japan expansion, Pfizer 25-valent PCV and More

Respiratory Research Update – 29 May 2026: JASCAYD Japan Approval, BEAM-302 AATD Data and More

Gene and Cell Therapy Update – 28 May 2026: Vyjuvek UK Approval, RGX-202 Phase 3 and More

Women’s Health Update – 27 May 2026: Enhertu Expansion, Datroway Approval and More

Neuroscience Update – 27 May 2026: TEV-749 EMA Acceptance, BIIB122 Miss and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 26 May 2026: EU AI Screening Push and More

Obesity Update – 26 May 2026: Lilly Retatrutide, Vincentage VCT220 and More

Oncology Update – 25 May 2026: Enhertu Breast Cancer Approval, Datroway TNBC and More

Public Health Update – 22 May 2026: WHO warns SDG setback risk, fabricated citations surge and More

Cardiovascular Update – 21 May 2026: Baxfendy Approval, Asundexian NDAs and More

Rare Diseases Update – 21 May 2026: HYMPAVZI EU Approval, Angelini-Catalyst Deal and More

Immunology Update – 20 May 2026: Sotyktu EU Approval, Mabwell FDA IND and More

Endocrinology Update – 19 May 2026: Sandoz Insulin Biosimilars, Sogroya Korea and More

Hematology Update – 18 May 2026: INQOVI AML FDA Approval, HYMPAVZI EU Expansion and More

Vaccines Update – 15 May 2026: Moderna Phase 3 flu efficacy, maternal Tdap meta-analysis and More

Respiratory Research Update – 15 May 2026: MD-712 Filing, CXG87 NDA and More

Gene and Cell Therapy Update – 14 May 2026: CASGEVY, ATSN-201 Data and More

Women’s Health Update – 13 May 2026: VEPPANU FDA Approval, POHERDY EU Approval and More

Neuroscience Update – 13 May 2026: Auvelity, Kisunla and More

Obesity Update – 12 May 2026: Eli Lilly GLP-1 Demand Surge, MariTide Switch Study and More

Artificial Intelligence and Digital Health Update – 12 May 2026: FDA AI, Roche-PathAI Deal and More

Oncology Update – 11 May 2026: VEPPANU Approval, Zipalertinib NDA and More

Public Health Update–8 May 2026: Pembrolizumab CRC durability, Argentina hantavirus outbreak & More

Rare Diseases Update – 7 May 2026: Intellia BLA, Tavneos Withdrawal and More

Cardiovascular Update – 7 May 2026: Aficamten Hits Endpoints, FDA Relay Pro Warning and More

Immunology Update – 6 May 2026: Rhapsido, Saphnelo Pen and More

Endocrinology Update – 5 May 2026: Tzield Pediatric Expansion, Semaglutide Teens Data and More

Hematology Update – 4 May 2026: Blenrep China Approval, Jakafi XR Approval and More

Respiratory Research Update – 30 Apr 2026: ENFLONSIA EU Approval, Breztri Asthma Approval and More

Vaccines Research Update – 30 Apr 2026: EU approval of flu-COVID vaccine, H5 Phase 3 advance & More

Gene and Cell Therapy Update – 30 Apr 2026: Otarmeni Approval, Kelonia Deal and More

Neuroscience Update – 29 Apr 2026: CAPLYTA sNDA, Itvisma CHMP and More

Women’s Health Update – 29 Apr 2026: Sun Pharma-Organon, Phase 3 Afuresertib and More

Obesity Update – 28 Apr 2026: Lilly Oral GLP-1 Launches, FDA Foundayo Safety and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 28 April 2026: GPT-Rosalind Launch and More

Oncology Update – 27 Apr 2026: Ifinatamab Priority Review, Ojemda EU Approval and More

Public Health Update – 24 April 2026: Gene Therapy Hearing Breakthrough, AI Chatbot Safety and More

Rare Diseases Update – 23 Apr 2026: Filspari approved in FSGS, ENSPRYNG MOGAD data and more

Cardiovascular Update – 23 Apr 2026: Trilogy launch in US, UK approval for Bayer's Kerendia and More

Immunology Update – 22 Apr 2026: Dupixent EU CSU, Saphnelo Canada SLE and More

Endocrinology Update – 21 Apr 2026: DENOZA Approval, Biocon Launch and More

Hematology Update – 20 Apr 2026: Jaypirca Phase 3 Success, OPN-6602 Fast Track and More

Vaccines Research Update – 17 Apr 2026: Marburg Trial, Nuvaxovid Canada and More

Respiratory Update – 17 Apr 2026: Generic Nintedanib Approval, Exdensur China Nod and More

Gene and Cell Therapy Update – 16 Apr 2026: UX111 BLA Accepted, WU-CART-007 Breakthrough and More

Women’s Health Update – 15 Apr 2026: At-home HPV screening clearance, CRB-701 FDA alignment

Neuroscience Update – 15 Apr 2026: Spinraza Higher-Dose FDA Approval and More

Obesity Update – 14 Apr 2026: FDA Clears Foundayo, Wegovy HD Launch and More

Oncology Update – 14 Apr 2026: KEYTRUDA EU Approval, Bezuclastinib NDA and More

Public Health Update – 10 Apr 2026: Phthalates Linked to Early Birth, Multi-Cancer Blood Test & More

Rare Diseases Update – 9 Apr 2026: AVLAYAH FDA Approval, VYKAT XR Deal and More

Cardiovascular Update – 9 Apr 2026: Repatha Benefit, FDA Breakthrough AI and More

Immunology Update – 8 April 2026: Rezurock EU Approval, Fabhalta Phase 3 and More

Endocrinology Update – 7 Apr 2026: FDA Approves Awiqli, GZR4 Phase 3 Success and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 6 April 2026: Lilly Insilico deal and More

Hematology Update – 6 Apr 2026: Sarclisa SC EU Opinion, DARZALEX Self-Admin and More

Vaccines Update – 3 April 2026: VAX-31 Phase 3, Qdenga India Nod and More